In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Published Date: 22 Mar 2024

It is recommended that dostarlimab and pembrolizumab regimens be implemented "as of yesterday.".

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Woman Loses 6-Year Battle With Mouth Tumor

2.

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

3.

A video animation guide to assist young people who are fatigued from cancer.

4.

FDA Expands Approval of Osimertinib in Lung Cancer

5.

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot